Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Cantor Fitzgerald
Moodys
Queensland Health
Federal Trade Commission
Chubb
Fish and Richardson
Argus Health

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020925

« Back to Dashboard

NDA 020925 describes TAVIST-1, which is a drug marketed by Glaxosmithkline Cons and Novartis and is included in two NDAs. Additional details are available on the TAVIST-1 profile page.

The generic ingredient in TAVIST-1 is clemastine fumarate. There are two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clemastine fumarate profile page.
Summary for 020925
Tradename:TAVIST-1
Applicant:Glaxosmithkline Cons
Ingredient:clemastine fumarate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020925

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.34MG
Approval Date:Aug 21, 1992TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Covington
Teva
Julphar
Dow
QuintilesIMS
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.